As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Cardio-Oncology Program

Rush has taken the necessary steps to ensure it's a safe place for treatment. Learn more.
U.S. News award badge

Thanks to advances in diagnosis and treatment, today more and more people are surviving cancer. 

But some of the chemotherapy drugs and radiation therapies that help you become cancer-free can also damage your heart. This can lead to new heart problems — especially if you are already at high risk for heart disease — or make existing conditions worse. 

There are many cardiovascular issues linked with chemotherapy and/or radiation therapy, such as arrhythmias, coronary artery blockages, heart attack, heart failure, high or low blood pressure, and valve disease. Chemotherapy may also cause certain cardiovascular risk factors (e.g., tyrosine-kinase-inhibitor-induced hypertension) to develop.

Because the risk of heart disease from cancer therapies can last a lifetime, proper post-treatment monitoring is essential for cancer survivors.

The cardio-oncology program at Rush is here to help by offering the following:

  • Evaluation and medical care to enhance your heart function before cancer-related procedures or surgery
  • Treatments to prevent or minimize damage to your heart while you are being treated for cancer (without changing your cancer regimen)
  • Assessment of and treatment for heart damage caused by past cancer treatments